The trophectoderm acts as a niche for the inner cell mass through C/EBPα-regulated IL-6 signaling

Stem Cell Reports. 2022 Sep 13;17(9):1991-2004. doi: 10.1016/j.stemcr.2022.07.009. Epub 2022 Aug 11.

Abstract

IL-6 has been shown to be required for somatic cell reprogramming into induced pluripotent stem cells (iPSCs). However, how Il6 expression is regulated and whether it plays a role during embryo development remains unknown. Here, we describe that IL-6 is necessary for C/EBPα-enhanced reprogramming of B cells into iPSCs but not for B cell to macrophage transdifferentiation. C/EBPα overexpression activates both Il6 and Il6ra genes in B cells and in PSCs. In embryo development, Cebpa is enriched in the trophectoderm of blastocysts together with Il6, while Il6ra is mostly expressed in the inner cell mass (ICM). In addition, Il6 expression in blastocysts requires Cebpa. Blastocysts secrete IL-6 and neutralization of the cytokine delays the morula to blastocyst transition. The observed requirement of C/EBPα-regulated IL-6 signaling for pluripotency during somatic cell reprogramming thus recapitulates a physiologic mechanism in which the trophectoderm acts as niche for the ICM through the secretion of IL-6.

Keywords: C/EBP transcription factor; IL-6 signaling; gene regulation; inner cell mass; pre-implantation embryo development; somatic cell reprogramming; transdifferentiation; trophectoderm.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blastocyst
  • CCAAT-Enhancer-Binding Protein-alpha* / genetics
  • CCAAT-Enhancer-Binding Protein-alpha* / metabolism
  • Embryonic Development
  • Interleukin-6* / metabolism
  • Morula / metabolism

Substances

  • CCAAT-Enhancer-Binding Protein-alpha
  • Interleukin-6